EntryPoint Capital LLC Makes New Investment in Teleflex Incorporated (NYSE:TFX)

EntryPoint Capital LLC purchased a new stake in shares of Teleflex Incorporated (NYSE:TFX) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 3,499 shares of the medical technology company’s stock, valued at approximately $623,000.

A number of other large investors have also recently modified their holdings of TFX. Vontobel Holding Ltd. raised its position in Teleflex by 21.9% during the 4th quarter. Vontobel Holding Ltd. now owns 1,393 shares of the medical technology company’s stock valued at $248,000 after purchasing an additional 250 shares in the last quarter. JPMorgan Chase & Co. increased its stake in shares of Teleflex by 14.3% during the third quarter. JPMorgan Chase & Co. now owns 155,158 shares of the medical technology company’s stock valued at $38,374,000 after buying an additional 19,466 shares during the period. Sumitomo Mitsui Trust Group Inc. raised its holdings in shares of Teleflex by 5.2% in the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 108,231 shares of the medical technology company’s stock valued at $19,263,000 after acquiring an additional 5,322 shares in the last quarter. Lecap Asset Management Ltd. purchased a new stake in Teleflex in the fourth quarter worth about $729,000. Finally, Mirae Asset Global Investments Co. Ltd. grew its holdings in Teleflex by 35.1% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 5,875 shares of the medical technology company’s stock worth $1,053,000 after acquiring an additional 1,527 shares in the last quarter. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Price Performance

Shares of TFX stock opened at $141.62 on Tuesday. Teleflex Incorporated has a fifty-two week low of $128.55 and a fifty-two week high of $249.91. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The firm has a market capitalization of $6.57 billion, a price-to-earnings ratio of 28.16, a PEG ratio of 1.73 and a beta of 1.21. The stock’s 50-day simple moving average is $162.43 and its 200-day simple moving average is $192.97.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, topping the consensus estimate of $3.86 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The company had revenue of $795.40 million for the quarter, compared to the consensus estimate of $813.24 million. As a group, equities analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were given a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 0.96%. The ex-dividend date was Friday, March 7th. Teleflex’s payout ratio is 95.77%.

Analyst Ratings Changes

Several brokerages have recently weighed in on TFX. Wells Fargo & Company lowered their price target on shares of Teleflex from $214.00 to $146.00 and set an “equal weight” rating for the company in a research report on Friday, February 28th. Citizens Jmp cut Teleflex from an “outperform” rating to a “market perform” rating in a research report on Thursday, February 27th. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research report on Wednesday, March 12th. Truist Financial dropped their price objective on Teleflex from $200.00 to $149.00 and set a “hold” rating on the stock in a research report on Monday, March 3rd. Finally, Morgan Stanley reduced their target price on shares of Teleflex from $275.00 to $191.00 and set an “overweight” rating for the company in a report on Wednesday, March 5th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $182.63.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.